CAS: 124-06-1; Ethyl Tetradecanoate

相似化合物

112-72-1 544-63-8 124-25-4

上下游产品

CAS号1427085-04-8 ethyl 4-oxo-6-(... | CAS号64-17-5 乙醇 | CAS号544-63-8 肉豆蔻酸 | CAS号2969-81-5 4-溴丁酸乙酯 | CAS号17049-50-2 癸基溴化镁 | CAS号112-64-1 肉豆蔻酰氯 | CAS号126-84-1 2,2-二乙氧基丙烷 | CAS号142-58-5 肉豆蔻酰胺MEA | CAS号638-58-4 正十四烷基铵 | CAS号629-63-0 十四腈 | CAS号544-63-8 肉豆蔻酸 | CAS号112-72-1 十四醇 | CAS号2507-55-3 2-羟基十四烷酸 | CAS号20478-71-1 tetradecanehydrazide | CAS号5805-25-4 2-tridecyl-1H-b... | CAS号5136-46-9 1,2-双(十四酰胺基)乙烷

Ethyl 4-Oxo-6-(5-(3-Oxobutyl)Furan-2-yl)Hexanoate置于64% Ni/sio2,氢气体系中,用 乙醇,甲醇 用作溶剂,75.0~242.0 °C,3.34 Mpa 条件下,反应 48.2H,反应生成五甲基呋喃溴酸酯,十四酸乙酯
参考文献:Method Of Producing Saturated Alkyl Esters/acids
标题:Method Of Producing Saturated Alkyl Esters/acids
摘要:本文披露了从呋喃材料生产饱和脂肪族酯或酸的方法.起始化合物含有呋喃,酮和酯或酸官能团,并且可能是生物衍生的.该方法包括将起始化合物加氢以形成还原混合物.该方法进一步包括将还原混合物进行脱氧反应,从而产生饱和脂肪族酯或酸.饱和脂肪族酯或酸可以是直链或支链的.酯和酸产品具有广泛的应用,并且可以进一步加工成适用于消费品中的表面活性剂,溶剂和润滑剂.

专利信息

专利号:US-7344868-B2
优先权日:2003-06-03
标题:Method for synthesizing ceramide-type compounds
发明人：LASSALLE LAURENT; YVERGNAUX FLORENT
权利人:LASSALLE LAURENT; YVERGNAUX FLORENT
摘要:The invention relates to the fields of fatty substance chemistry, specifically of the ceramide-type compound synthesis. The invention resides substantially in the synthesis of ceramide-type compounds. Specifically, the aim of the invention is a new enzymatic synthesis method, comprising at least one amidification step and one esterification step, achieved through lipases, among fatty acids and/or esters thereof and amino alcohols. The resulting ceramide-type compounds can be used as cosmetic and/or pharmaceutical compositions, in particular as dermatological compositions in conjunction or in admixture with one or more suitable cosmetic and/or pharmaceutical excipients or carriers. The method has an interest particularly in the synthesis of active compounds useful in the fields of cosmetology and/or pharmacology and specifically of dermatology.

专利号:CN-104910009-A
优先权日:2015-06-25
标题 :A kind of method of ionic liquid catalyzed synthesis of pletil alcohol ester

专利号:US-2014186905-A1
优先权日:2011-08-15
标题 :Biotechnological synthesis process of organic compounds with the aid of an alkl gene product
发明人：SCHAFFER STEFFEN; GIELEN JASMIN; DECKER NICOLE; KIRCHNER NICOLE; HAAS THOMAS; POETTER MARKUS; HAEGER HARALD
权利人:SCHAFFER STEFFEN; GIELEN JASMIN; DECKER NICOLE; KIRCHNER NICOLE; HAAS THOMAS; POETTER MARKUS; HAEGER HARALD; EVONIK DEGUSSA GMBH
摘要:Subject matter of the invention is a biotechnological process for the production of organic compounds with the aid of at least one alkL gene product.

专利号:US-6949553-B2
优先权日:2001-06-18
标题 :Aliphatic compounds, their synthesis method, and utilization of the same
发明人：TAMAI TADAKAZU; YOSHIKAI KAZUYOSHI; NISHIKAWA MASAZUMI; OGASAWARA KUNIO; MUROTA ITSUKI
权利人:MARUHA CORP
摘要:The present invention relates to aliphatic compounds of the formula I, or stereoisomers thereof, or their pharmaceutically acceptable salts: n n nwherein A represents an optionally substituted CH 3 C n H (2n-2m) — (wherein n denotes an integer of 4 to 22, and m represents an unsaturation number which is an integer of 0 to 7), l represents an integer of 0 to 10, s represents 0 or 1, provided that when s is 0, p+q=4 or 5, but when s is 1, p+q=3 or 4, and in each case, either p or q is an integer of 1 or more, R represents an alkyl group having 1 to 10 carbon atoms which may be straight-chain or branched-chain, and R A represents hydrogen or an alkyl group having 1 to 10 carbon atoms which may be straight-chain or branched-chain, and their use in suppression of platelet aggregation, in suppression of inflammation, and in prevention and treatment of circulatory diseases.

专利号:US-4975441-A
优先权日:1988-03-23
标 题:Lactams, their synthesis and use in cosmetic compositions
发明人：GIBSON WALTER T
权利人:UNILEVER PATENT HOLDINGS
摘要:A composition suitable for topical application to mammalian skin or hair for inducing, maintaining or increasing hair growth comprises: (i) a chemical inhibitor of glycosidase activity chosen from lactams having the structure: where A<1> and A<6> are -H, -CH3, - @@0, -CH2OT or @@@0 A<1> and A<6> being the same or different, and at least one of which being the group: @ @@o in a lactam ring; and where Q is -OT min , -NHT min or a lactam linkage to A<1> or A<6>; the Q groups being the same or different, and at least one of which is involved in a lactam linkage; and where T is the same or different and is chosen from -H, -CpH2p+1 or a metal ion, T min is -H or -COCpH2p+1, and p is an integer of from 1 to 22; provided that: where any of the Q groups is -OT min or -NHT min , then that group or groups can be of either stereochemical configuration with respect to the plane of the ring; and (ii) a cosmetically acceptable vehicle for the chemical inhibitor. Certain novel lactams are also claimed.

专利号:US-2020330400-A1
优先权日:2016-03-16
标 题:Methods for the treatment of cancer using coenzyme q10 and fatty acid metabolism inhibitors
发明人：GESTA STEPHANE; DIERS ANNE R; DADALI-ABEL TULIN
权利人:BERG LLC
摘要:Presented herein are methods for the treatment of oncological disorders by the co-administration of CoQ10 compositions and at least one fatty acid metabolism inhibitor. In one embodiment, the CoQ10 compositions are lipid-containing compositions. The fatty acid metabolism inhibitor may be an inhibitor of fatty acid synthesis, storage, transport or degradation. The fatty acid metabolism inhibitor may also be a modulator of fatty acid structure, for example a fatty acid desaturase or elongase. The fatty acid inhibitor may inhibit any molecule involved in fatty acid metabolism, such as fatty acid synthase (FASN), carnitine palmitoyltransferase 1 (CPT-1), long-chain 3-ketoacyl-CoA thiolase, or stearoyl-CoA desaturase-1 (SCD-1). In embodiments, the fatty acid metabolism inhibitor may be C75, Etomoxir, trimetazidine or A939572.